fyremadel contains the active substance ganirelix and belongs to a group of medicines called "anti-gonadotropin-releasing hormones" which counteract the effect of natural gonadotropin-releasing hormone ( GnRH ). GnRH controls the release of one of the gonadotropins (luteinizing hormone ( LH ) and follicle-stimulating hormone ( FSH )). Gonadotropins play an important role in human fertility and reproduction. In women, FSH is needed for the growth and maturation of follicles in the ovaries. Folliclesare small round blisters that contain egg cells. LH is needed for the mature egg cells to detach from the follicles and ovaries (ie ovulation). Fyremadel counteracts the effect of GnRH , which
Medicines dose side effects combinations
2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg film-coated tablets perampanel
90 mg / ml powder and solvent for injection , solution Enfuvirtide
0 mg tablets furosemide
40 mg tablets furosemide
25 mg tablets furosemide
40 mg tablets furosemide
10 mg / ml solution for injection / infusion furosemide
30 mg, 60 mg prolonged-release capsules furosemide
10 mg / ml injection solution furosemide
5 mg and 50 mg nitrofurantoin tablets
20 mg / ml shampoo Ketoconazole
250 mg solution for injection in a pre-filled syringe fulvestrant
250 mg solution for injection, pre-filled syringe fulvestrant
250 mg solution for injection in a pre-filled syringe fulvestrant
250 mg soaking liquid, solution in pre-filled syringe fulvestrant
50mg solution for injection in a pre-filled syringe fulvestrant
250 mg solution for injection in a pre-filled syringe fulvestrant
250 mg solution for injection in a pre-filled syringe fulvestrant
6 mg solution for injection in a pre-filled syringe of pegfilgrastim
1% eye ointment fusidic acid